JPRN-UMIN000031330Not yet recruitingPhase 4
Exploratory study of clinical effectiveness and safety of TJ-116 bukuryoingohangekobokuto for anxiety and postoperative water brash in esophageal cancer patients - Investigation of TJ-116 bukuryoingohangekobokuto for postoperative water brash in esophageal cancer.
Department of Education and Support for Regional Medicine. Department of Kampo medicine0 sites24 target enrollmentStarted: February 16, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Not yet recruiting
- Sponsor
- Enrollment
- 24
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Patients who have past history of abdominal surgery 2 Patients who have past history of ileus 3 Patients with concomitant inflammatory bowel disease such as ulcerative colitis and crohn disease 4. Eemergent surgery 5. Patients who took prohibited concomitant drugs 4 weeks before treatment 6. Patients who have past history of radiotherapy and radiation chemotherapy for esophageal cancer 7. Patients who have past history of allergy for other Kampo formulation(s) 8. Patients who have serious concomitant diseases 9. A woman who is pregnant, has a possibility of pregnancy, is within 28 days after birth, is breastfeeding 10. Dementia patients 11. Others, including patients who are unfit for the study as determined by the attending physician
Investigators
Similar Trials
Recruiting
Not Applicable
Exploratory study of clinical effectiveness and safety of daikenchuto (TJ-100) for gastrointestinal symptoms such as abdominal pain and distention following laparoscopic colectomy in colon cancer patientsColon cancerJPRN-UMIN000023318Department of gastrointestinal surgery, Kyoto University40
Recruiting
Phase 4
Investigation of TJ-116 bukuryoingohangekobokuto for postoperative water brash in esophageal cancer.D004938Esophageal canceresophageal cancerJPRN-jRCTs021190001Ishii Tadashi24
Not yet recruiting
Unknown
A study to assess the clinical effectiveness and safety of intravesical mitomycin-C and gemcitabine sequential therapy in patients with high risk non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG) Therapy: Prospective, multicenter, open-label trialKCT0009491ational Cancer Center82
Recruiting
Not Applicable
Prospective study for clinical effectiveness and safety of TAZ/PIPC for the prevention of infectious complication of high risk lung cancer surgeryMalignant lung tumorJPRN-UMIN000003532Department of General Thoracic Surgery, Graduate School of Medicine, Chiba University50
Active, not recruiting
Not Applicable
The clinical efficiency of positive airway pressure (PAP) treatment in patients with moderate-severe obstructive sleep apnea syndrome (OSAS)Obstructive sleep apneaRespiratory - Sleep apnoeaACTRN12613000373774Sabri Koseoglu75